HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $3.4M of Halozyme Therapeutics, Inc.
Sold$3,433,875
$68.68Price
50,000Shares
−6%Stake
What HALO did after the filing
- The stock from Thu, May 14 open, $70.03
- +10.2%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Jun 29 close.
Traded Mon, May 11. Filed Wed, May 13, 5:50 PM ET, after the close. Returns use the May 14 open and the Jun 29 close. Not investment advice.